Seasonal Variation in Fibrinogen in the Rotterdam Study

Summary

As evidence accumulates to implicate fibrinogen as a risk indicator for cardiovascular disease, it is of interest to study its seasonal variation. A population based cross-sectional study was performed among participants of the Rotterdam Study, a cohort of 7,983 men and women, aged 55 years and over. Fibrinogen levels were measured by the prothrombin time derived method in the first 2,325 participants of the study. Fibrinogen levels were considerably higher in winter. The seasonal difference was 0.34 g/1 (95% confidence interval 0.29,0.39) and was more pronounced in subjects aged 75 years and over than in subjects aged 55 to 75 years, 0.43 g/1 (0.34,0.52) and 0.29 g/1 (0.24,0.35), respectively. Additional adjustment for body mass index, systolic and diastolic blood pressure, and total and HDL cholesterol did not materially change the findings. After adjustment for seasons, outdoor temperature was not associated with fibrinogen. Adjustment for outdoor temperature did not change the seasonal variation of fibrinogen, seasonal difference 0.31 g/1 (0.24, 0.37). In conclusion, fibrinogen levels are highest in Winter. The seasonal variation of fibrinogen is more pronounced in the elderly. Outdoor temperature does not seem to play a role in the seasonal variation of fibrinogen. Seasonal variation of fibrinogen may partly explain the increased cardiovascular disease mortality in Winter.

• References

• 1 Sakamoto-Momiyama M. Changes in the seasonality of human mortality: a medico-geographical study. Soc Sci Med 1978; 12: 29-42
• 2 Mackenbach JP, Kunst AE, Looman CWN. Seasonal variation in mortality in The Netherlands. J Epidemiol Comm H 1992; 46: 261-265
• 3 Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade T. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994; 343: 435-439
• 4 Stout RW, Crawford V. Seasonal variations in fibrinogen concentrations among elderly people. Lancet 1991; 338: 09-13
• 5 Folsom AR, Wu KK, Conlan MG, Finch A, Davis CE, Marcucci G, Sorlie PD SzkloM. Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethnicity Dis. 1992; 02: 35-46
• 6 Pan WH, Li LA, Tsai MJ. Temperature extremes and mortality from coronary heart disease and cerebral infarction in elderly Chinese. Lancet 1995; 345: 353-355
• 7 Hofman A, Grobbee DE, de JongPTVM, van den OuwelandFA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. EurJ Epidemiol 1991; 07: 403-422
• 8 Rose GA, Blackburn H, Gillum RF. Cardiovascular survey methods. World Health Organization; Geneva, Switzerland: 1982
• 9 van der BomJG, Bots ML, de BruijnAM, Hofman A, Grobbee DE. Measurement of p-thromboglobulin in the elderly. Findings from the Rotterdam Study. Fibrinolysis 1994; 08 Suppl 02 157-159
• 10 Rossi E, Mondonico P, Lombardi A, Preda L. Method for determination of functional (clottable) fibrinogen by the new ACL coagulometers. Thromb Res 1988; 52: 453-468
• 11 Von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 231-237
• 12 van Gent CM, van der Voort HA, de Bruijn AM. Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures. Clin Chim Acta 1977; 75: 243-251
• 13 Rao CR. Linear statistical inference and its applications. 02. nd ed. New York: Wiley; 1973: 418-419
• 14 Collins KJ. Low indoor temperatures and morbidity in the elderly. Age Ageing 1986; 15: 212-220
• 15 Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northield TC, Mendall MA. Fibrinogen, a link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634-1635
• 16 Moshkowitz M, Konikoff FM, Arber N, Peled Y, Santo M, Bujanover Y, Gilat T. Seasonal variation in the frequency of Helicobacter Pylori infection: a possible cause of the seasonal occurrence of peptic ulcer disease. Am J Gastroentrol 1994; 89: 731-733
• 17 Crawford VLS, Sweeney O, Coyle P, Halliday MI, McDermott MJ, Stout RW. Are winter infections responsible for seasonal changes in fibrinogen levels in elderly people?. Fibrinolysis 1996; 10 Suppl 01 02 (Abstract).
• 18 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller J. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
• 19 Heinrich J, Balleissen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of Coronary Risk. Results from the PROCAM Study in Healthy men. Arterioscl Thromb 1994; 14: 54-59
• 20 Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-641
• 21 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischemic heart disease: Principle results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537